Surveillance and medical protocols are in place, but environmental factors for the epidemic reappearing regularly cannot be ruled out.

How fast does a fish disappear? How long does it take to erase all evidence of its life, to turn it into a fillet? What about ...

Three De-suup trainees, a man and two women, have died at the national referral hospital after a Leptospirosis outbreak at a ...

The report provides a detailed analysis of the current acute respiratory distress syndrome (ARDS) marketed drugs and late-stage pipeline drugs. Inside the ARDS Market | How Tech, Awareness, Rising ...

Abstract and Introduction Background: Over the last decade, several studies have suggested that survival rates for patients with acute lung injury (ALI) or ARDS may have improved. We performed a ...

Over the last 7 days, the United States market has risen by 1.7%, and over the past year, it is up 12%, with earnings forecasted to grow by 15% annually. For investors seeking opportunities beyond ...

Introduction Acute respiratory distress syndrome (ARDS) is a sudden and serious lung injury in the intensive care unit (ICU), which is characterized by deterioration of alveolar-vascular permeability ...

Cardiorenal syndrome (CRS) commonly occurs during treatment of acute decompensated heart failure (ADHF) and is associated with poor clinical outcome. The pathophysiology of CRS entails a complex ...

The R/I ratio showed limited accuracy in predicting lung recruitability in ARDS but reliably identified low recruiters.

NORTH BRUNSWICK, N.J., June 17, 2025 (GLOBE NEWSWIRE) -- BioAegis Therapeutics, a pioneering biotech company at the forefront of innovative therapies for inflammatory diseases, announces that the U.S.

In the U.S. alone, ARDS affects over 500,000 patients per year, or roughly 10% of all ICU admissions. With no effective pharmacological therapies currently available for ARDS and its high ...